Journal
FOOD SCIENCE AND HUMAN WELLNESS
Volume 10, Issue 4, Pages 452-459Publisher
KEAI PUBLISHING LTD
DOI: 10.1016/j.fshw.2021.04.007
Keywords
Antioxidant; Anti-proliferation; Dietary mushrooms; HeLa cells; Novel Mushrooms; Thymol
Categories
Funding
- Prince Sattam bin Abdulaziz University
Ask authors/readers for more resources
This study identified a unique isoform of 18S rRNA gene from a novel wild mushroom SMK-1 and found that the main bioactive compound in its methanolic extract was thymol. The phenolic and flavonoid fractions of SMK-1 showed antioxidant and anti-proliferative effects, with high potential for therapeutic benefits in inhibiting oxidative stress and developing new natural drugs.
Mushrooms are good sources of phytochemicals that have antioxidant and anti-proliferative effects. This study identified a unique isoform of 18S rRNA gene (864 bp) from a novel wild mushroom (SMK-1) (GenBank accession number: SUB3267363). Thin layer chromatographic (TLC) profiling of the methanolic extract of the dried mushroom fruiting bodies of SMK-1 revealed the presence of phenolic and flavonoid fractions with retention factor (Rf) values of 0.955 and 0.927 respectively. The GC/MS chromatograms of the SMK-1 methanolic extract identified the main bioactive compound was phenol, 5-methyl-2-(1-methylethyl) (74.00%) (thymol). The radical scavenging activity for the flavonoid fraction was greater than the phenolic fractions (Rfphenolics fractions > Rfflavonoid fractions) with the antioxidant activity more than that of standard ascorbic acid. Also, the phenolic and flavonoid fractions of SMK-1 expressed cytotoxic effects in HeLa cells with IC50 values ranging from 5 mu g/mL to 80 mu g/mL in a dose-dependent manner. This present research highlights the presence of high thymol concentration in a novel wild mushroom that has antioxidant and anti-poliferative potential with therapeutic benefits. The application of thymol natural products from novel mushroom SMK-1 as nutrition supplements could inhibit oxidative stress triggered by numerous pathologies that may pave the way to develop a new therapeutic natural drug. (C) 2021 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available